PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.9

Change

-0.16 (-1.77)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.48 (-1.56%)

USD 11.35B
QLD ProShares Ultra QQQ

-0.62 (-0.62%)

USD 7.34B
FNGU MicroSectors FANG+ Index 3X Le..

-6.98 (-1.60%)

USD 5.84B
SSO ProShares Ultra S&P500

-0.38 (-0.43%)

USD 5.40B
UPRO ProShares UltraPro S&P500

-0.57 (-0.68%)

USD 4.05B
TECL Direxion Daily Technology Bull..

-0.24 (-0.29%)

USD 3.44B
YINN Direxion Daily FTSE China Bull..

+0.55 (+1.65%)

USD 2.18B
USD ProShares Ultra Semiconductors

+0.16 (+0.13%)

USD 1.31B
LABU Direxion Daily S&P Biotech Bul..

-0.16 (-0.13%)

USD 0.91B
DPST Direxion Daily Regional Banks ..

-2.97 (-2.76%)

USD 0.74B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1,622.58% 94% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,622.58% 94% A 98% N/A
Trailing 12 Months  
Capital Gain 2,279.68% 94% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,279.68% 94% A 98% N/A
Trailing 5 Years  
Capital Gain 793.87% 91% A- 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 793.87% 91% A- 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 38.72% 70% C- 91% A-
Dividend Return 39.22% 70% C- 91% A-
Total Return 0.49% 38% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 325.11% 15% F 3% F
Risk Adjusted Return 12.06% 24% F 31% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.